GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (FRA:TRB) » Definitions » Pre-Tax Income

Trinity Biotech (FRA:TRB) Pre-Tax Income : €-34.21 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Trinity Biotech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Trinity Biotech's pretax income for the three months ended in Dec. 2023 was €-5.04 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-34.21 Mil. Trinity Biotech's pretax margin was -40.96%.

During the past 13 years, Trinity Biotech's highest Pretax Margin was 22.90%. The lowest was -70.02%. And the median was -28.53%.


Trinity Biotech Pre-Tax Income Historical Data

The historical data trend for Trinity Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Pre-Tax Income Chart

Trinity Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.00 -5.45 -1.70 -41.33 -33.86

Trinity Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.84 -5.90 -17.18 -6.09 -5.04

Competitive Comparison of Trinity Biotech's Pre-Tax Income

For the Diagnostics & Research subindustry, Trinity Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Pre-Tax Income falls into.



Trinity Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Trinity Biotech's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-14.62+-10.181+-9.306+0+0.245
=-33.86

Trinity Biotech's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.198+-0.263+-1.272+-0.555+0.244
=-5.04

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-34.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trinity Biotech  (FRA:TRB) Pre-Tax Income Explanation

Trinity Biotech's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-5.044/12.313
=-40.96%

During the past 13 years, Trinity Biotech's highest Pretax Margin was 22.90%. The lowest was -70.02%. And the median was -28.53%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trinity Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech (FRA:TRB) Business Description

Traded in Other Exchanges
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.

Trinity Biotech (FRA:TRB) Headlines

No Headlines